162 related articles for article (PubMed ID: 1483493)
1. Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.
van Baak MA; Mooij JM; Schiffers PM
Eur J Clin Pharmacol; 1992; 43(5):547-50. PubMed ID: 1483493
[TBL] [Abstract][Full Text] [Related]
2. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W
Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077
[TBL] [Abstract][Full Text] [Related]
4. Extent and pharmacokinetic mechanisms of oral atenolol-verapamil interaction in man.
Keech AC; Harper RW; Harrison PM; Pitt A; McLean AJ
Eur J Clin Pharmacol; 1988; 35(4):363-6. PubMed ID: 3197744
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
Wójcicki J; Wojciechowski G; Wójcicki M; Kostyrka R; Sterna R; Gawronska-Szklarz B; Pawlik A; Drozdzik M; Kozlowski K
Eur J Clin Pharmacol; 2000 Apr; 56(1):75-9. PubMed ID: 10853882
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
[TBL] [Abstract][Full Text] [Related]
8. The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.
Elliott HL; Meredith PA; McNally C; Reid JL
Br J Clin Pharmacol; 1991 Sep; 32(3):379-85. PubMed ID: 1777376
[TBL] [Abstract][Full Text] [Related]
9. The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.
McCourty JC; Silas JH; Tucker GT; Lennard MS
Br J Clin Pharmacol; 1988 Mar; 25(3):349-57. PubMed ID: 3358897
[TBL] [Abstract][Full Text] [Related]
10. Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol.
Carmona MJ; Pereira VA; Malbouisson LM; Auler JO; Santos SR
Braz J Med Biol Res; 2009 Jun; 42(6):574-81. PubMed ID: 19448909
[TBL] [Abstract][Full Text] [Related]
11. [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Telatyńska-Smieszek B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
Pol Arch Med Wewn; 2004 Jan; 111(1):45-51. PubMed ID: 15088420
[TBL] [Abstract][Full Text] [Related]
12. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
[TBL] [Abstract][Full Text] [Related]
13. Prolonged beta blockade due to tertatolol: a comparative study with propranolol and atenolol.
Desche P; Cournot A; Guery O; Prost JF; Duchier J
Fundam Clin Pharmacol; 1987; 1(4):253-6. PubMed ID: 3501763
[TBL] [Abstract][Full Text] [Related]
14. Synergistic adverse hemodynamic interaction between oral verapamil and propranolol.
Carruthers SG; Freeman DJ; Bailey DG
Clin Pharmacol Ther; 1989 Oct; 46(4):469-77. PubMed ID: 2791449
[TBL] [Abstract][Full Text] [Related]
15. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.
Wilmore JH; Freund BJ; Joyner MJ; Hetrick GA; Hartzell AA; Strother RT; Ewy GA; Faris WE
Am J Cardiol; 1985 Apr; 55(10):135D-141D. PubMed ID: 3993545
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
[TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
Telatyńska B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
Pol J Pharmacol; 2003; 55(1):81-9. PubMed ID: 12856830
[TBL] [Abstract][Full Text] [Related]
18. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects.
Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
J Clin Pharmacol; 1993 Aug; 33(8):756-61. PubMed ID: 8408738
[TBL] [Abstract][Full Text] [Related]
19. The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults.
Panton LB; Guillen GJ; Williams L; Graves JE; Vivas C; Cediel M; Pollock ML; Garzarella L; Krumerman J; Derendorf H
J Clin Pharmacol; 1995 Sep; 35(9):885-94. PubMed ID: 8786248
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies.
Venkatesh G; Ramanathan S; Mansor SM; Nair NK; Sattar MA; Croft SL; Navaratnam V
J Pharm Biomed Anal; 2007 Mar; 43(4):1546-51. PubMed ID: 17157469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
